✦ LIBER ✦

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease

✍ Scribed by Craig H. Moskowitz; Tarun Kewalramani; Stephen D. Nimer; Maria Gonzalez; Andrew D. Zelenetz; Joachim Yahalom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes for patients who fail high dose

✍ Alison J. Moskowitz; Miguel-Angel Perales; Tarun Kewalramani; Joachim Yahalom; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

High-dose chemotherapy and autologous st

✍ El Weshi, A; Rahal, M; Abdelsalam, M; Al Husseini, H; Maghfoor, I; Akhtar, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 200 KB

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

High-dose chemotherapy with autologous s

✍ Czyż, J; Hellmann, A; Dziadziuszko, R; Hansz, J; Goździk, J; Hołowiecki, J; Stel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Prognostic factors for disease progressi

✍ Popat, U; Hosing, C; Saliba, R M; Anderlini, P; Besien, K van; Przepiorka, D; Kh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Double high-dose therapy for Hodgkin’s d

✍ Stewart, D A; Guo, D; Glück, S; Morris, D; Chaudhry, A; deMetz, C; Klassen, J; B 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB